Ribbon Bio

Ribbon Bio is a Vienna-based synthetic biology company that has developed a proprietary, algorithm-driven platform to synthesize pristine, long, and complex DNA molecules (MiroSynth™). This technology addresses a critical bottleneck in the field by providing scarless, adapter-free linear DNA up to 12 kb and circular DNA up to 20 kb with high accuracy, even for difficult sequences. The company operates as a platform and service provider, partnering with other organizations to enable next-generation applications in therapeutics, diagnostics, and other sectors, positioning itself as a key enabler in the rapidly growing synthetic biology market.

Algorithm-driven platform for synthesizing pristine, long, and complex synthetic DNA molecules (MiroSynth™ Linear up to 12 kb, Circular up to 20 kb) with high accuracy, designed to handle difficult sequences including high GC content and repeats.

Ribbon Bio competes in the DNA synthesis market against large players like Twist Bioscience and GenScript, as well as newer enzymatic synthesis companies like DNA Script. Its differentiation is based on a claimed superior ability to synthesize long, complex, and pristine sequences in a scarless format, a niche where current technologies are limited.